Clofazimine-induced cutaneous hyperpigmentation as a source of stigma in the treatment of leprosy: A cross-sectional study.
Andreza Soares NogueiraMonique Allana Chagas GarciaMoises Batista da SilvaPatricia Fagundes da CostaMarco Andrey Cipriani FradeClaudio Guedes SalgadoJosafá Gonçalves BarretoPublished in: Tropical medicine & international health : TM & IH (2024)
All patients presented skin hyperpigmentation caused by clofazimine, detectable through spectrophotometry. Hyperpigmentation strongly impacted the social domain, indicating the intersectionality of disease and skin colour stigma, contributing to the social isolation of these patients. Health authorities should consider the negative impact of clofazimine on treatment adherence.
Keyphrases
- end stage renal disease
- mental health
- healthcare
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- public health
- prognostic factors
- hiv aids
- type diabetes
- mental illness
- social support
- oxidative stress
- depressive symptoms
- social media
- drug induced
- health information
- patient reported
- endothelial cells
- high glucose
- replacement therapy
- diabetic rats